ROIVANT SCIENCES LTD. COMMON SHARES SALES AGREEMENTSales Agreement • September 19th, 2022 • Roivant Sciences Ltd. • Pharmaceutical preparations • New York
Roivant Sciences Ltd. as the Company and as Trustee Subordinated Indenture Dated as of [_____]Subordinated Indenture • September 19th, 2022 • Roivant Sciences Ltd. • Pharmaceutical preparations • New York
WHEREAS, the Company has duly authorized the issue from time to time of its subordinated debentures, notes or other evidences of indebtedness to be issued in one or more series (the “Securities”) up to such principal amount or amounts as may from time to time be authorized in accordance with the terms of this Indenture and to provide, among other things, for the authentication, delivery and administration thereof, the Company has duly authorized the execution and delivery of this Indenture; and
Roivant Sciences Ltd. as the Company and as Trustee Senior Indenture Dated as of [_____]Senior Indenture • September 19th, 2022 • Roivant Sciences Ltd. • Pharmaceutical preparations • New York
SENIOR INDENTURE, dated as of [_____], between Roivant Sciences Ltd., a Bermuda exempted limited company, as the Company, and [_____], as Trustee.
